These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11405411)

  • 21. Effects of dual-chamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and on diastolic function.
    Betocchi S; Losi MA; Piscione F; Boccalatte M; Pace L; Golino P; Perrone-Filardi P; Briguori C; Franculli F; Pappone C; Salvatore M; Chiariello M
    Am J Cardiol; 1996 Mar; 77(7):498-502. PubMed ID: 8629591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms.
    ten Berg JM; van Tooren R; Jaarsma W; Suttorp MJ; Plokker HW
    J Am Coll Cardiol; 1998 Nov; 32(5):1485. PubMed ID: 9809970
    [No Abstract]   [Full Text] [Related]  

  • 23. Dual chamber pacing in hypertrophic cardiomyopathy: long-term effects on diastolic function.
    Betocchi S; Elliott PM; Briguori C; Virdee M; Losi MA; Matsumura Y; Miranda M; McKenna WJ; Chiariello M
    Pacing Clin Electrophysiol; 2002 Oct; 25(10):1433-40. PubMed ID: 12418740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy.
    McAreavey D; Fananapazir L
    Am J Cardiol; 1992 Sep; 70(6):651-6. PubMed ID: 1510015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of hypertrophic cardiomyopathy with mid-ventricular obstruction (MVO) -- dramatic long-term improvement with a DDD pacemaker as assessed by diastolic paradoxical jet flow velocity.
    Sasaki Y; Inoue T; Beppu H; Shirasawa K; Kida Y; Takeda S; Ayukawa H; Shirasaka A; Kakio T; Doi T; Hashimoto T; Kawai C
    Int J Cardiol; 2011 Jul; 150(2):217-9. PubMed ID: 21663981
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy.
    Dimitrow PP; Podolec P; Grodecki J; Płazak W; Dudek D; Pieniazek P; Bacior B; Legutko J; Olszowska M; Kostkiewicz M; Kawecka-Jaszcz K; Tracz W; Dubiel JS
    Int J Cardiol; 2004 Mar; 94(1):31-4. PubMed ID: 14996471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report.
    Haruki S; Minami Y; Kajimoto K; Yashiro B; Suzuki T; Kawana M; Hagiwara N
    Eur J Heart Fail; 2010 Jan; 12(1):94-7. PubMed ID: 19942605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy.
    Minami Y; Kajimoto K; Kawana M; Hagiwara N; Sherrid MV
    Int J Cardiol; 2010 May; 141(2):195-7. PubMed ID: 19097655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are there sex differences following treatment of left ventricular outflow tract obstruction in adults with hypertrophic cardiomyopathy?
    Chahal AA; Alhurani RE; Mohamed EA; Somers VK; Miller VM; Murad MH; Ahmed AT
    Eur Heart J Qual Care Clin Outcomes; 2017 Jul; 3(3):249-250. PubMed ID: 28838090
    [No Abstract]   [Full Text] [Related]  

  • 30. Contemporary treatment of hypertrophic cardiomyopathy.
    Marian AJ
    Tex Heart Inst J; 2009; 36(3):194-204. PubMed ID: 19568388
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of left ventricular outflow obstruction due to hypertrophic cardiomyopathy. Role of multimodality echocardiographic techniques.
    Luckie M; Khattar RS
    Minerva Cardioangiol; 2011 Dec; 59(6):581-9. PubMed ID: 22134470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient bradycardia induced by carotid sinus pressure increases outflow obstruction in hypertrophic obstructive cardiomyopathy but not in valvular aortic stenosis.
    Klein HO; Keren G; Bakst A; Laniado S; Lang R; Kaplinsky E; Di Segni E
    Chest; 1998 Aug; 114(2):469-76. PubMed ID: 9726732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients.
    Lakkis N; Plana JC; Nagueh S; Killip D; Roberts R; Spencer WH
    Am J Cardiol; 2001 Sep; 88(5):583-6. PubMed ID: 11524078
    [No Abstract]   [Full Text] [Related]  

  • 35. Dyssynchronization reduces dynamic obstruction without affecting systolic function in patients with hypertrophic obstructive cardiomyopathy: a pilot study.
    Giraldeau G; Duchateau N; Bijnens B; Gabrielli L; Penela D; Evertz R; Mont L; Brugada J; Berruezo A; Sitges M
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1179-88. PubMed ID: 27146905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid return of left ventricular outflow tract obstruction and symptoms following cessation of long-term atrioventricular synchronous pacing for obstructive hypertrophic cardiomyopathy.
    Gadler F; Linde C; Rydén L
    Am J Cardiol; 1999 Feb; 83(4):553-7. PubMed ID: 10073860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interventional treatments for hypertrophic cardiomyopathy.
    Mohiddin SA; Knight C
    Cardiovasc Ther; 2012 Jun; 30(3):e107-14. PubMed ID: 21883992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction: Expecting the Unexpected.
    Jain P; Patel PA; Fabbro M
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):467-477. PubMed ID: 28967624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptomatic obstructive hypertrophic cardiomyopathy.
    Sorajja P; Ommen SR; Nishimura RA
    Circ Cardiovasc Interv; 2013 Oct; 6(5):586-91. PubMed ID: 24129935
    [No Abstract]   [Full Text] [Related]  

  • 40. Left ventricular outflow tract obstruction in the presence of asymmetric septal hypertrophy and accessory mitral valve tissue treated with alcohol septal ablation.
    Kim MS; Klein AJ; Groves BM; Quaife RA; Salcedo EE
    Eur J Echocardiogr; 2008 Sep; 9(5):720-4. PubMed ID: 18490281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.